NASDAQ · Medical - Diagnostics & Research

Check-Cap Ltd. Ordinary Share (MBAI) Stock

$1.31 -7.09% NASDAQ: MBAI Healthcare

Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology.

Valuation

MetricValue
Price$1.31
Market Cap$9.20M
P/E Ratio1.98
P/B Ratio2.38
P/S Ratio0.00
EPS (TTM)$0.66
52-Week High$3.92
52-Week Low$0.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE416.71%
ROA55.30%
ROCE-69.04%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.05

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-17.0M$-20.0M$-19.0M$-26.0M$-2.0M
Net Profit$-17.0M$-19.0M$-18.0M$-25.0M$4.0M
EPS$-3.03$-3.37$-3.00$-4.30$0.66
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$56.0M$45.0M$25.0M$0$7.0M
Total Liabilities$5.0M$4.0M$1.0M$2.0M$4.0M
Cash$26.0M$4.0M$9.0M$0$0
Borrowings$1.0M$1.0M$0$0$0

Latest News

Check-Cap: MBody AI Advances Its Robot Fleet Operating System with Multi-Robot Control GlobeNewswire · Jul 16, 2026 Check-Cap: MBody AI Brings AI Robotics to Buyers Edge Platform Operators, Manufacturers and Distributors GlobeNewswire · Jul 14, 2026 Check-Cap: MBody AI Expands Robotics Footprint Across U.S. and Canada GlobeNewswire · Jun 29, 2026 Check-Cap Presents MBody AI Robotics Platform at Planet MicroCap and Northland Growth Conferences in June 2026 GlobeNewswire · Jun 10, 2026 Check-Cap Presents MBody AI Robotics Platform at Miami Investor Summit GlobeNewswire · May 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-16.0M$-19.0M$-17.0M$-8.0M$0
Investing Cash Flow$-17.0M$-13.0M$21.0M$-1.0M$0
Financing Cash Flow$19.0M$0$0$0$0
Net Cash Flow$19.0M$-22.0M$4.0M$-24.0M$0
Free Cash Flow$-17.0M$-19.0M$-17.0M$-8.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA2.11
FCF Yield-0.50%
Quick Ratio0.05
Interest Coverage-12.83
Return 1Y95.52%
Return 3Y-59.82%
Return 5Y-93.99%

Ownership

Insiders Held37.48%
Institutions Held0.46%
Institutions Float Held0.73%
Institutional HolderSharesReport Date
UBS Group AG22,7522026-03-31
BNP Paribas Financial Markets4,4352026-03-31
JPMORGAN CHASE & CO1,5002026-03-31
Aviso Financial Inc.1002026-03-31
Royal Bank of Canada1102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Check-Cap Ltd. Ordinary Share

Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.

Check-Cap Ltd. Ordinary Share is led by CEO David Lontini, employs 85 people, headquartered in IL, publicly traded since 2015.

Check-Cap Ltd. Ordinary Share (MBAI) stock trades at $1.31 with a market capitalization of $9.20M. The stock is valued at a price-to-earnings (P/E) ratio of 1.98, price-to-book of 2.38, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.60 and $3.92, and currently trades 66.6% below its 52-week high.

On profitability, Check-Cap Ltd. Ordinary Share generates a return on equity (ROE) of 416.71% — well above the market average, a sign of a high-quality business, return on capital employed of -69.04%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: check-cap.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides